Well disclosed admirer.
Added at 6.1 today. Own view is that it may not be cheaper in view of increased production and demand.
Who knows in these times?
Brave of you with dow futures not looking pretty but I have the same feeling as to how there doing
CONCLUSIONS: The daily administration ofBLIS K12 to children attending their first year ofkindergarten was associated with a significantreduction in episodes of streptococcal pharyngitis and acute otitis media. No protection againstscarlet fever was detected.
Results: The 20 adults who completed the 90-day course of Bactoblis® showed a reduction in their episodes of streptococcal pharyngeal infection (about 80%). The 90 days treatment was also associated with an approximately 60% reduction in the incidence of reported pharyngitis in the 6-month period following use of the product. The product was well tolerated by the subjects with no treatment-related side effects or drop-outs reported.
CONCLUSIONS: The daily administration ofBLIS K12 to children attending their first year ofkindergarten was associated with a significantreduction in episodes of streptococcal pharyngitis and acute otitis media. No protection againstscarlet fever was detected.
Results: The 20 adults who completed the 90-day course of Bactoblis® showed a reduction in their episodes of streptococcal pharyngeal infection (about 80%). The 90 days treatment was also associated with an approximately 60% reduction in the incidence of reported pharyngitis in the 6-month period following use of the product. The product was well tolerated by the subjects with no treatment-related side effects or drop-outs reported.
Not a great study to consider as a gold standard.. and end point to difficult to correlate for cause and effect.
I don't have a PHD is health science so can't make an educated opinion as to whether or not the 30 odd trials are a crock.
After reviewing supporting science and safety publications, Health Canada has approved products containing BLIS K12 to bear claim language such as, the product “promotes oral health [through the re-colonisation of the oral cavity]”, that it is an “oral probiotic for re-colonisation of the oral cavity after antibiotic treatment”, that “following oral antimicrobial rinsing Streptococcus salivarius K12 supplementation helps reduce volatile sulfur compound levels (halitosis)”, and that it “can help reduce the incidence of
Streptococcal pharyngitis/tonsillitis (sore throats caused by pathogenic xvariants belonging to the Streptococcus genus)”.
Not a great study to consider as a gold standard.. and end point to difficult to correlate for cause and effect.
Sorry, I would have thought the fact that I said 'quick Google' as opposed to 'exhaustive research' might clarify what I did. I didn't know I was supposed to be proving 'gold standard'. I'm not the company, just a punter reading a bit of a souped up blog.
Just remember this is a heavily traded stock by the institutions, so don't read into up or down movements of the SP too much, and position appropriately.
Trade fundamentals , and technicals if you want good entry points
Originally Posted by patrick
Reply With Quote
Bookmarks